This announcement is a separate document:
罗欣药业：关于替戈拉生片新适应症获得药品注册证书的公告
Luoxin Pharmaceutical: Announcement on obtaining a drug registration certificate for the new indications of tigoracin tablets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated